Literature DB >> 22565497

Uncovering the source of new benzodiazepine prescriptions in community-dwelling older adults'.

Alex S Halme1, Sarah-Gabrielle Beland, Michel Preville, Cara Tannenbaum.   

Abstract

OBJECTIVE: Initiatives to reduce benzodiazepine use have been largely unsuccessful despite strong associations with adverse outcomes. Curtailing incident use of benzodizepines is an alternate strategy that has yet to be explored. This study aims to determine the source of incident benzodiazepine prescriptions by comparing the risk of receiving a new prescription upon hospital discharge versus after an ambulatory care clinic visit.
METHODS: Data were derived from 1189 community-dwelling adults aged 65 years naive to benzodiazepine consumption, enrolled in the Étude sur la Santé des Ainés, a prospective 3-year cohort study conducted in Québec, Canada. Health survey questionnaires were linked with provincial administrative databases of prescription and health service claims. Analysis with multivariate Poisson regression models compared the risk of incident benzodiazepine use post-hospitalization versus after an ambulatory care visit. Models were adjusted for sex, age, antidepressant use, and concomitant drugs. Sub-analyses were conducted for chronic prescriptions.
RESULTS: Incident benzodiazepine use was 11% over a 2-year period, with 18.3% of prescriptions leading to chronic use (> 90 days). Hospitalization conferred a 2.7-fold greater risk of incident use than an outpatient visit (OR 2.66, 95% CI 1.78-3.98) and a 4.7-fold (OR 4.74, 95% CI 1.63-13.78) increased risk of chronic use, after adjusting for potential confounders. Despite the increased risk, only 13% of new prescriptions originated post-hospital discharge, with the remainder prescribed during outpatient visits.
CONCLUSION: Interventions are required to curb incident benzodiazepine prescriptions at their source both in hospitals and in ambulatory care settings.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22565497     DOI: 10.1002/gps.3818

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  10 in total

1.  Long-term cognitive and functional effects of potentially inappropriate medications in older women.

Authors:  Alain Koyama; Michael Steinman; Kristine Ensrud; Teresa A Hillier; Kristine Yaffe
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-11-29       Impact factor: 6.053

Review 2.  Deprescribing Benzodiazepines in Older Patients: Impact of Interventions Targeting Physicians, Pharmacists, and Patients.

Authors:  Brendan J Ng; David G Le Couteur; Sarah N Hilmer
Journal:  Drugs Aging       Date:  2018-06       Impact factor: 3.923

3.  Sedative-hypnotic medicines and falls in community-dwelling older adults: a cost-effectiveness (decision-tree) analysis from a US Medicare perspective.

Authors:  Cara Tannenbaum; Vakaramoko Diaby; Dharmender Singh; Sylvie Perreault; Mireille Luc; Helen-Maria Vasiliadis
Journal:  Drugs Aging       Date:  2015-04       Impact factor: 3.923

4.  Association between chiropractic spinal manipulative therapy and benzodiazepine prescription in patients with radicular low back pain: a retrospective cohort study using real-world data from the USA.

Authors:  Robert James Trager; Zachary A Cupler; Kayla J DeLano; Jaime A Perez; Jeffery A Dusek
Journal:  BMJ Open       Date:  2022-06-13       Impact factor: 3.006

5.  Predicting chronic benzodiazepine use in adults with depressive disorder: Retrospective cohort study using administrative data in Quebec.

Authors:  Jean-Daniel Carrier; Pasquale Roberge; Josiane Courteau; Alain Vanasse
Journal:  Can Fam Physician       Date:  2016-08       Impact factor: 3.275

6.  Effects of a geriatric intervention aiming to improve quality care in nursing homes on benzodiazepine use and discontinuation.

Authors:  Philipe de Souto Barreto; Maryse Lapeyre-Mestre; Philippe Cestac; Bruno Vellas; Yves Rolland
Journal:  Br J Clin Pharmacol       Date:  2016-01-08       Impact factor: 4.335

7.  Benzodiazepine use among older adults with chronic obstructive pulmonary disease: a population-based cohort study.

Authors:  Nicholas T Vozoris; Hadas D Fischer; Xuesong Wang; Geoffrey M Anderson; Chaim M Bell; Andrea S Gershon; Anne L Stephenson; Sudeep S Gill; Paula A Rochon
Journal:  Drugs Aging       Date:  2013-03       Impact factor: 3.923

8.  Point Prevalence Survey of Benzodiazepine and Sedative-Hypnotic Drug Use in Hospitalized Adult Patients.

Authors:  Heather L Neville; Mia Losier; Jennifer Pitman; Melissa Gehrig; Jennifer E Isenor; Laura V Minard; Ellen Penny; Susan K Bowles
Journal:  Can J Hosp Pharm       Date:  2020-06-01

Review 9.  Managing therapeutic competition in patients with heart failure, lower urinary tract symptoms and incontinence.

Authors:  Cara Tannenbaum; Kristina Johnell
Journal:  Drugs Aging       Date:  2014-02       Impact factor: 3.923

10.  Addressing Barriers to Reducing Prescribing and Implementing Deprescribing of Sedative-Hypnotics in Primary Care.

Authors:  Lisa Burry; Justin Turner; Timothy Morgenthaler; Cara Tannenbaum; Hyung J Cho; Evelyn Gathecha; Flora Kisuule; Abi Vijenthira; Christine Soong
Journal:  Ann Pharmacother       Date:  2021-07-23       Impact factor: 3.154

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.